SUMMARY

Neela Gil Technologies company primarily focuses on developing oral insulin nanotechnology to improve the lives of insulin-dependent diabetes patients. Their innovative approach revolves around a nanotechnology-based encapsulation process, ensuring the protection of insulin from degradation by gastric pH and enzymes. The company's unique selling point lies in its cutting-edge technology that makes insulin administration more convenient and less invasive than traditional methods. This technological advancement positions Neela Gil distinctively in the healthcare market, particularly for diabetes care. Neela Gil Technologies has attracted attention and funding from various angel investors and venture capital firms, indicating strong confidence in its innovative approach and market potential. The company's mission is to revolutionize diabetes treatment through its novel oral insulin delivery system, catering to a significant and growing market of diabetes patients worldwide. Their focus areas and continuous innovation in this field set them apart from competitors in the healthcare technology sector.

PRODUCTS

Insulin capsule for diabetics, using nanotechnology for oral delivery

SERVICES

A universal platform technology capable of encapsulating various protein therapeutics

FOUNDER DETAILS

ABOUT

Innovating in healthcare, NeelAgil Technologies pioneers oral insulin capsules and protein therapeutic encapsulation.

COMPANY TYPE

SERVICE VERTICALS

• Medical Diagnostics

TECHNOLOGY

• Biosensors
• Cloud
• Machine Learning / Deep Learning

THERAPEUTIC AREAS

• Diabetes

VALUE OFFERING

• Research
• Diagnosis
• Clinical Workflow

LOCATION

Neelagil Technologies Private Limited registered address is FLAT NO- 202, B/A WINGSWAPNA NAGARI, BARAVE,,THANE,Thane-421301,Maharashtra

TARGET USERS

• HCP
• Corporate

INCORPORATION DATE

December 11, 2017

STATE/CITY

Maharashtra, Mumbai